What are the symptoms and treatment options for depression in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Depression in Adults

Depression is characterized by depressed mood or loss of interest/pleasure (anhedonia) along with at least 5 total symptoms lasting at least 2 weeks that impair normal functioning. 1

Core Diagnostic Symptoms

The two cardinal symptoms that define depression are:

  • Depressed mood - feeling down, sad, or hopeless most of the day, nearly every day 2, 1
  • Anhedonia - markedly diminished interest or pleasure in activities that were previously enjoyable 2, 1

At least one of these two core symptoms must be present for diagnosis. 1

Additional Diagnostic Symptoms

To meet diagnostic criteria, at least 5 total symptoms (including one of the core symptoms above) must be present during the same 2-week period:

  • Sleep disturbances - insomnia or hypersomnia nearly every day 2, 1
  • Fatigue or loss of energy - persistent tiredness even without exertion 2, 1
  • Appetite changes - significant weight loss/gain or changes in appetite 2
  • Low self-view - feelings of worthlessness or excessive/inappropriate guilt 2
  • Concentration difficulties - diminished ability to think, concentrate, or make decisions 2
  • Psychomotor changes - agitation or retardation observable by others 2, 1
  • Thoughts of self-harm - recurrent thoughts of death or suicidal ideation 2

Severity Assessment

Depression severity is classified based on symptom count, intensity, and functional impairment:

  • Mild depression: PHQ-9 score 5-9 or minimal functional impairment 2, 1
  • Moderate depression: PHQ-9 score 10-14 or moderate functional impairment 2, 1
  • Severe depression: PHQ-9 score 15-27 or marked functional impairment 2, 1

Screening Tools

The PHQ-9 is the recommended validated screening tool, starting with the 2-item version asking about depressed mood and anhedonia. 2, 1

  • If the 2-item PHQ score is 0-1, no further screening is needed 2
  • If the 2-item PHQ score is 2-3, complete the full 9-item questionnaire 2
  • Alternative validated tools include the Hamilton Depression Rating Scale (HAM-D) and Hospital Anxiety and Depression Scale (HADS) 2

Critical Red Flags Requiring Emergency Evaluation

Any patient expressing suicidal ideation or risk of harm to self/others requires immediate referral for emergency psychiatric evaluation. 2, 3

  • Suicidal thinking and behavior risk is highest in the first few months of antidepressant treatment, particularly in patients under age 24 3
  • Emergence of agitation, panic attacks, severe insomnia, irritability, hostility, or impulsivity may represent precursors to suicidality 3

Common Comorbidities to Assess

  • Anxiety disorders: 50-60% of patients with depression have comorbid anxiety, most commonly generalized anxiety disorder 2
  • Substance use disorders: Common in untreated depression and worsen prognosis 1
  • Bipolar disorder screening: Essential before initiating antidepressants, as treating unrecognized bipolar depression with antidepressants alone may precipitate manic episodes 3

Treatment Options

First-Line Treatments

Either cognitive behavioral therapy (CBT) or second-generation antidepressants (SSRIs/SNRIs) are equally effective first-line treatments for moderate depression. 1, 4

  • For mild depression, start with CBT alone 1
  • For moderate to severe depression, initiate either CBT or antidepressants based on patient preference, cost, and side effect concerns 1
  • For severe depression, combination therapy (CBT + antidepressant) is superior to monotherapy, nearly doubling remission rates (57.5% vs 31.0%) 1, 4

Pharmacotherapy Specifics

  • SSRIs (fluoxetine, escitalopram, citalopram) or SNRIs (venlafaxine, duloxetine) are first-line medications 1
  • SNRIs are slightly more effective than SSRIs but have higher rates of nausea and vomiting 1
  • Selection should be based on adverse effect profiles, drug interactions, prior treatment response, and patient preference 2
  • Therapeutic effects typically require 4-6 weeks at adequate doses 1

Psychotherapy Options

Effective psychotherapy modalities include:

  • Cognitive behavioral therapy (CBT) 1, 4
  • Behavioral activation 4
  • Interpersonal therapy (IPT) 4
  • Problem-solving therapy 4
  • Brief psychodynamic therapy 4

Treatment Duration

  • Continue treatment for at least 4-9 months after satisfactory response for first episodes 1
  • For recurrent depression, continue treatment for ≥1 year or longer 1
  • Premature discontinuation is a common pitfall leading to relapse 1

Monitoring and Follow-Up

  • Assess treatment response within 1-2 weeks of initiation, monitoring for therapeutic effects, adverse effects, and suicidality 1
  • If inadequate response by 6-8 weeks, modify treatment through dose adjustment, medication switching, or augmentation strategies 1
  • Close monitoring significantly improves treatment success, with collaborative care programs showing substantial symptom improvement (SMD 0.42) compared to usual care 4

Special Considerations

Medical Causes

Always first treat underlying medical causes of depressive symptoms (unrelieved pain, fatigue) and delirium (infection, electrolyte imbalance) before attributing symptoms to primary depression. 2, 5

Marital/Relationship Issues

When depression occurs with significant marital distress, behavioral couples therapy should be added to individual CBT 6

Treatment-Resistant Depression

  • Defined as failure to respond to two or more adequate antidepressant trials (sufficient dose and duration, minimum 4 weeks) 1
  • Second-line options include switching antidepressants, adding a second antidepressant, or augmenting with non-antidepressant medications 4

References

Guideline

Diagnostic Criteria and Treatment Options for Major Depressive Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Mood Disorders Secondary to Medical Conditions or Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Approach for Depression in Adults with Marital Issues

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.